{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:51:50Z","timestamp":1770987110602,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.ejphar.2005.10.019","type":"journal-article","created":{"date-parts":[[2005,11,29]],"date-time":"2005-11-29T12:41:32Z","timestamp":1133268092000},"page":"141-149","source":"Crossref","is-referenced-by-count":9,"title":["Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: Differential effects on lisinopril and zofenopril"],"prefix":"10.1016","volume":"527","author":[{"given":"Bart","family":"Westendorp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regien G.","family":"Schoemaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiek H.","family":"van Gilst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk J.","family":"van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Buikema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.10.019_bib1","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/sj.bjp.0703498","article-title":"Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure","volume":"130","author":"Buikema","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.10.019_bib2","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/ndt\/13.7.1682","article-title":"The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide","volume":"13","author":"Buter","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2005.10.019_bib3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0895-7061(02)02995-3","article-title":"Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species","volume":"15","author":"Cominacini","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2005.10.019_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1015709617405","article-title":"Pathophysiologic and therapeutic importance of tissue ACE: a consensus report","volume":"16","author":"Dzau","year":"2002","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2005.10.019_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1681\/ASN.2004060505","article-title":"Diuretic and enhanced sodium restriction results in improved antiproteinuric response to ras blocking agents","volume":"16","author":"Esnault","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2005.10.019_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/147323000503300103","article-title":"Antioxidant and cardioprotective properties of the sulphydryl angiotensin-converting enzyme inhibitor zofenopril","volume":"33","author":"Evangelista","year":"2005","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ejphar.2005.10.019_bib7","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0735-1097(01)01161-5","article-title":"Are all angiotensin-converting enzyme inhibitors interchangeable?","volume":"37","author":"Furberg","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2005.10.019_bib8","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/01.CIR.0000090572.51900.92","article-title":"Should evidence-based proof of drug efficacy be extrapolated to a \u201cclass of agents\u201d?","volume":"108","author":"Furberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2005.10.019_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000186753","article-title":"Sodium depletion enhances the antiproteinuric effect of ACE inhibition in established experimental nephrosis","volume":"60","author":"Gansevoort","year":"1992","journal-title":"Nephron"},{"key":"10.1016\/j.ejphar.2005.10.019_bib10","doi-asserted-by":"crossref","first-page":"H1229","DOI":"10.1152\/ajpheart.00207.2003","article-title":"Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction","volume":"285","author":"Hayashidani","year":"2003","journal-title":"Am. J. Physiol.: Heart Circ.Physiol."},{"key":"10.1016\/j.ejphar.2005.10.019_bib11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ki.1989.190","article-title":"Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril","volume":"36","author":"Heeg","year":"1989","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2005.10.019_bib12","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1161\/01.CIR.86.5.1566","article-title":"Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure","volume":"86","author":"Hirsch","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2005.10.019_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.CIR.0000030935.89559.04","article-title":"Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure","volume":"106","author":"Jorde","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2005.10.019_bib14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1042\/cs0920455","article-title":"Tissue expression of components of the renin-angiotensin system in experimental post-infarction heart failure in rats: effects of heart failure and angiotensin-converting enzyme inhibitor treatment","volume":"92","author":"Kelly","year":"1997","journal-title":"Clin. Sci. (Lond)"},{"key":"10.1016\/j.ejphar.2005.10.019_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1042\/cs0900031","article-title":"Cardiomegaly and vasoactive hormones in rats with chronic myocardial infarction: long-term effects of chlorothiazide","volume":"90","author":"Kohzuki","year":"1996","journal-title":"Clin. Sci. (Lond)"},{"issue":"Suppl 2","key":"10.1016\/j.ejphar.2005.10.019_bib16","first-page":"77","article-title":"The effects of age and renal impairment on the pharmacokinetics of co-administered lisinopril and hydrochlorothiazide","volume":"5","author":"Laher","year":"1991","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.ejphar.2005.10.019_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jacc.2003.06.021","article-title":"What is the optimal serum potassium level in cardiovascular patients?","volume":"43","author":"Macdonald","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2005.10.019_bib18","first-page":"992","article-title":"Pharmacokinetics and pharmacodynamics of zofenopril in healthy volunteers","volume":"49","author":"Marzo","year":"1999","journal-title":"Arzneim.-Forsch."},{"key":"10.1016\/j.ejphar.2005.10.019_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005344-198706000-00016","article-title":"Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patients","volume":"9","author":"Navis","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.10.019_bib20","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/cvr\/27.11.1933","article-title":"Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology","volume":"27","author":"Pinto","year":"1993","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2005.10.019_bib21","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1023\/A:1015823315983","article-title":"Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors","volume":"9","author":"Ranadive","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejphar.2005.10.019_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/heart.88.5.525","article-title":"Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP","volume":"88","author":"Reinhardt","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.ejphar.2005.10.019_bib23","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/01.CIR.0000125741.88712.77","article-title":"Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of angiotensin-converting enzyme inhibitor","volume":"109","author":"Sakata","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2005.10.019_bib24","first-page":"E612","article-title":"Expression of components of the RAS during prolonged blockade at different levels in primates","volume":"267","author":"Samani","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2005.10.019_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/01.RES.72.2.312","article-title":"Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II","volume":"72","author":"Schunkert","year":"1993","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2005.10.019_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/jmcc.2001.1497","article-title":"Effect of ramipril and furosemide treatment on interstitial remodeling in post-infarction heart failure rat hearts","volume":"34","author":"Seeland","year":"2002","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.ejphar.2005.10.019_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1388-9842(02)00242-8","article-title":"Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats","volume":"5","author":"Seeland","year":"2003","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2005.10.019_bib28","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ki.1993.378","article-title":"Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases","volume":"44","author":"Sorbi","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2005.10.019_bib29","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1053\/euhj.2001.2989","article-title":"The prognostic importance of creatinine clearance after acute myocardial infarction","volume":"23","author":"Sorensen","year":"2002","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2005.10.019_bib30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1527-3466.1999.tb00008.x","article-title":"Preclinical profile of zofenopril: an angiotensin converting enzyme inhibitor with peculiar cardioprotective properties","volume":"17","author":"Subissi","year":"1999","journal-title":"Cardiovasc. Drug Rev."},{"issue":"Suppl 5","key":"10.1016\/j.ejphar.2005.10.019_bib31","first-page":"69","article-title":"The pharmacokinetics of co-administered lisinopril and hydrochlorothiazide","volume":"2","author":"Swaisland","year":"1991","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.ejphar.2005.10.019_bib32","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/01.CIR.102.13.1556","article-title":"Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II","volume":"102","author":"van Kats","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2005.10.019_bib33","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/cvr\/25.11.936","article-title":"Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril","volume":"25","author":"van Wijngaarden","year":"1991","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2005.10.019_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3317\/jraas.2004.004","article-title":"Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction","volume":"5","author":"Westendorp","year":"2004","journal-title":"J.Renin. Angiotensin. Aldosterone. Syst."},{"key":"10.1016\/j.ejphar.2005.10.019_bib35","doi-asserted-by":"crossref","unstructured":"Westendorp, B., Schoemaker, R.G., Buikema, H., de Zeeuw, D., Boomsma, F., van Gilst, W.H., van Veldhuisen, D.J., in press. Beneficial effects of add-on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinapril. Eur.J.Heart Fail.","DOI":"10.1016\/j.ejheart.2004.12.002"},{"key":"10.1016\/j.ejphar.2005.10.019_bib36","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1161\/01.CIR.90.5.2457","article-title":"Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition","volume":"90","author":"Wollert","year":"1994","journal-title":"Circulation"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905010770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905010770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T05:13:46Z","timestamp":1554700426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905010770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":36,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0014299905010770"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.10.019","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}